Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Gastric Cancer

  Free Subscription


09.11.2026

2 BMC Cancer
1 BMC Gastroenterol
1 Br J Cancer
1 Cancer Lett
1 Endoscopy
3 Eur J Cancer
1 Int J Cancer
1 J Cancer Res Clin Oncol
1 J Clin Oncol
2 J Surg Oncol
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. HU Y, Zhu L, Zhou L, Zhang Y, et al
    Senescence-related immunosuppressive gene MFAP2 orchestrates stromal-immune crosstalk and immunotherapy resistance in gastric cancer.
    BMC Cancer. 2026;26:1337.
    PubMed         Abstract available

  2. YUE Q, Huang Y, Yu RX, Li KQ, et al
    Impact of previous abdominal surgery on perioperative outcomes after minimally invasive gastrectomy for gastric cancer: an evidence synthesis and quantitative analysis.
    BMC Cancer. 2026;26:1333.
    PubMed         Abstract available


    BMC Gastroenterol

  3. SONG J, Hou R, Yang L, Zhang H, et al
    Gastritis cystica profunda with early gastric cancer persisting for 9 years in the stage of high-grade intraepithelial neoplasia.
    BMC Gastroenterol. 2026;26:732.
    PubMed         Abstract available


    Br J Cancer

  4. NTELLAS P, Lund T, Keogh GA, Salto-Tellez M, et al
    The role of DNA mismatch repair status in oesophagogastric cancer treated with perioperative chemotherapy: evidence from the MRC ST03 and OE05 trials.
    Br J Cancer. 2026;135:1731-1742.
    PubMed         Abstract available


    Cancer Lett

  5. ZHANG YY, Ghelfi M, Xue Y, Chen H, et al
    CDK9 degradation suppresses gastroesophageal cancer growth and overcomes radiation resistance through chromatin remodeling and YAP1/TEAD downregulation.
    Cancer Lett. 2026;662:218916.
    PubMed         Abstract available


    Endoscopy

  6. NAM KA, Kang D, Lee J, Lee HY, et al
    Declining Cost-Effectiveness of Gastric Cancer Screening Over a Decade: A Cohort Modelling Study.
    Endoscopy. 2026 Nov 4. doi: 10.1055/a-2997-9672.
    PubMed         Abstract available


    Eur J Cancer

  7. CARMONA-BAYONAS A, Jimenez-Fonseca P, Capdevila J, Alonso V, et al
    Perioperative chemotherapy and long-term cure in resected grade 3 gastroenteropancreatic neuroendocrine carcinomas: The GETNE SOUTH-NEC Study.
    Eur J Cancer. 2026;248:117773.
    PubMed         Abstract available

  8. KAMP D, May AM, Kessels R, Slingerland M, et al
    Timing of first-line palliative systemic therapy in metastatic esophagogastric adenocarcinoma: A population-based analysis & target trial emulation.
    Eur J Cancer. 2026;248:117444.
    PubMed         Abstract available

  9. MASETTI M, Nieto A, Lorenzen S, Goetze TO, et al
    Biomarker-defined benefit from FLOT plus nivolumab in metastatic gastroesophageal cancer: Extended follow-up and immune-inflammatory markers of the phase II IKF-AIO-moonlight trial.
    Eur J Cancer. 2026;248:117037.
    PubMed         Abstract available


    Int J Cancer

  10. LI J, Yin X, Zhao G, Liu X, et al
    Fruit and Vegetable Intake in Relation to the Risks of Lung, Colorectal, Stomach, and Overall Cancers in China: A Prospective Cohort Study.
    Int J Cancer. 2027;160:98-109.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  11. MEYER HJ, Dermendzhiev T, Jacobs PP, Romeo D, et al
    Coronary artery calcification is not associated with survival in advanced gastric and gastroesophageal junction cancer: a secondary analysis of the EXPAND trial.
    J Cancer Res Clin Oncol. 2026;152:213.
    PubMed         Abstract available


    J Clin Oncol

  12. SHAH MA, Marzalik JS, Kennedy EB, Deighton D, et al
    Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2.
    J Clin Oncol. 2026;44:e170-e183.
    PubMed         Abstract available


    J Surg Oncol

  13. LEE FG, Hanson KT, Cross AE, Habermann EB, et al
    NSQIP Outcomes for Open and Minimally Invasive Gastrectomy for Malignancy.
    J Surg Oncol. 2026;134:947-957.
    PubMed         Abstract available

  14. OLECKI EJ, Holguin RP, Dixon MEB, Peng JS, et al
    Optimal Management of Clinical T2N0 Gastric Adenocarcinoma: Surgery or Chemotherapy First?
    J Surg Oncol. 2026;134:850-857.
    PubMed         Abstract available


    PLoS One

  15. CRUZ-DIAZ WE, Haro-Varas J, Enriquez-Vera D, De la Cruz Ku G, et al
    Clinicopathologic characteristics and survival outcomes of gastroenteropancreatic neuroendocrine neoplasms in Peru: A 15-year retrospective cohort study.
    PLoS One. 2026;21:e0361867.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum